VMY-1-103
A novel dansylated analog of purvalanol B, and a CDK inhibitor that inhibits cell cycle progression and proliferation in prostate and breast cancer cells more effectively than purvalanol B.
Product Specifications
CAS Number
1209002-43-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
708.27
Molecular Formula
C34H42ClN9O4S
Notes
Research use only, not for human use.
Receptor
CDK
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2031638-01 0.01 mg
Recombinant FK506 Binding Protein 12 Rapamycin Associated Protein (FRAP)
Ask
View Details 
MBS2031638-02 0.05 mg
Recombinant FK506 Binding Protein 12 Rapamycin Associated Protein (FRAP)
Ask
View Details MBS2031638-03 0.1 mg
Recombinant FK506 Binding Protein 12 Rapamycin Associated Protein (FRAP)
Ask
View Details 
MBS2031638-04 0.2 mg
Recombinant FK506 Binding Protein 12 Rapamycin Associated Protein (FRAP)
Ask
View Details MBS2031638-05 0.5 mg
Recombinant FK506 Binding Protein 12 Rapamycin Associated Protein (FRAP)
Ask
View Details MBS2031638-06 1 mg
Recombinant FK506 Binding Protein 12 Rapamycin Associated Protein (FRAP)
Ask
View Details